AstraZeneca, one of the frontrunners in the global race for a Covid-19 vaccine, announced Tuesday that it was pausing its late-stage trial to review safety data. The company said the pause is a “routine action” and that it is trying to expedite the review to “minimize any potential impact on the trial timeline.” 

The following data was compiled by Johns Hopkins University:

  • Global cases: More than 27.6 million
  • Global deaths: At least 898,200
  • U.S. cases: More than 6.32 million
  • U.S. deaths: At least 189,600

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *